ImCheck to Present Encouraging Interim Results in AML Patients from the EVICTION Trial at the 66th American Society of Hematology Annual Meeting
26 nov. 2024 05h00 HE
|
ImCheck Therapeutics SAS
ImCheck to Present Encouraging Interim Results in AML Patients from the EVICTION Trial at the 66th American Society of Hematology Annual Meeting Marseille, France, November 26, 2024, 11 am CET –...
Smart Immune to Present Details of Pioneering Clinical Study at the American Society of Hematology (ASH) Annual Meeting 2023
02 nov. 2023 09h00 HE
|
Smart Immune
Smart Immune to Present Details of Pioneering Clinical Study at the American Society of Hematology (ASH) Annual Meeting 2023 PARIS, France, 02 November 2023 – Smart Immune, a clinical-stage...
American Oncology Network Physicians Research Presented at 64th ASH Annual Meeting & Exposition
14 déc. 2022 09h55 HE
|
American Oncology Network
FORT MYERS, Fla., Dec. 14, 2022 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) is pleased to announce that seven research studies co-authored by AON physicians were presented at the...
Florida Cancer Specialists & Research Institute Research Breakthroughs Presented at Global Hematology Gathering
13 déc. 2022 09h17 HE
|
Florida Cancer Specialists & Research Institute
Fort Myers, Florida, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) that is contributing to global advancements in the...
Kura Oncology Announces Four Abstracts Accepted for Presentation at ASH Annual Meeting
03 nov. 2022 09h00 HE
|
Kura Oncology, Inc.
SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Dr. Owhofasa Agbedia to Receive the 2021 ASH-CIBMTR-ASTCT Career Development Award
22 juin 2022 11h00 HE
|
American Society for Transplantation and Cellular Therapy (ASTCT)
CHICAGO, June 22, 2022 (GLOBE NEWSWIRE) -- American Society for Transplantation and Cellular Therapy (ASTCT) is pleased to announce that Owhofasa Agbedia, MD, MPH, has been selected by the American...
American Oncology Network Physicians Research is Well Represented at the ASH Annual Meeting & Exposition
16 déc. 2021 07h00 HE
|
American Oncology Network
Fort Myers, Fla., Dec. 16, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) is pleased to announce that eight research studies co-authored by AON physicians were presented at the...
ExCellThera announces data to be presented at the American Society of Hematology 2021 annual meeting
29 nov. 2021 08h05 HE
|
ExCellThera
MONTRÉAL, Nov. 29, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical-stage cell expansion and engineering company delivering molecules and bioengineering solutions to expand and engineer...
Cellectis Reports Preliminary Results from its Phase 1 BALLI-01 Study of UCART22 in R/R Adult B-ALL at American Society of Hematology (ASH) Annual Meeting
05 déc. 2020 17h00 HE
|
Cellectis Inc.
Cellectis’ Proprietary Program UCART22 was Safely Administered in BALLI-01 Phase 1 Study with No Dose-Limiting Toxicity or Evidence of Graft-Vs-Host Disease 2 out of 3 Patients at DL1 Achieved...
Telo Genomics Announces that Positive Results of Smoldering Multiple Myeloma Study Selected for Online Publication Within ASH 2020 Proceedings
13 oct. 2020 09h15 HE
|
Telo Genomics Corp.
TORONTO, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) is pleased to announce that its abstract submitted to the American Society of Hematology (ASH)...